Michael Doubek

Research interests

Publications

• Management of ALL in adults: 2024 ELN recommendations from a European expert panel

  Blood · 2024 · https://doi.org/10.1182/blood.2023023568

• International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

  Blood · 2020 · https://doi.org/10.1182/blood.2019003453

• COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus

  Leukemia · 2020 · https://doi.org/10.1038/s41375-020-0959-x

• Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

  Blood · 2019 · https://doi.org/10.1182/blood-2018-09-873083

• International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

  The Lancet Haematology · 2019 · https://doi.org/10.1016/s2352-3026(19)30166-8

• Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

  Bone Marrow Transplantation · 2018 · https://doi.org/10.1038/s41409-018-0373-4

• Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

  Leukemia · 2018 · https://doi.org/10.1038/s41375-018-0210-1

• Chromothripsis in acute myeloid leukemia: biological features and impact on survival

  Leukemia · 2018 · https://doi.org/10.1038/s41375-018-0035-y

• Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project

  Cytometry Part B Clinical Cytometry · 2017 · https://doi.org/10.1002/cyto.b.21595

• Ibrutinib inhibits CD20 upregulation on CLL B cells mediated by the CXCR4/SDF-1 axis

  Blood · 2016 · https://doi.org/10.1182/blood-2016-04-709519

• Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia

  Blood Cancer Journal · 2016 · https://doi.org/10.1038/bcj.2016.84

• International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

  Haematologica · 2016 · https://doi.org/10.3324/haematol.2016.144311

• Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial

  The Lancet · 2015 · https://doi.org/10.1016/s0140-6736(15)60027-7

• Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

  Nature Genetics · 2015 · https://doi.org/10.1038/ng.3253

• A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

  Leukemia · 2015 · https://doi.org/10.1038/leu.2015.313

• Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

  Leukemia · 2014 · https://doi.org/10.1038/leu.2014.297

• Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2014.55.2018

• Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage

  Blood · 2009 · https://doi.org/10.1182/blood-2009-07-234708

• Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history ofMYH9-related disease

  Human Mutation · 2007 · https://doi.org/10.1002/humu.20661

Current projects

No projects listed.